1
|
Banks J, George J, Potter S, Gardiner MD, Ives C, Shaaban AM, Singh J, Sherriff J, Hallissey MT, Horgan K, Harnett A, Desai A, Ferguson DJ, Tillett R, Izadi D, Sadideen H, Jain A, Gerrand C, Holcombe C, Hayes A, Teoh V, Wyld L. Breast Angiosarcoma Surveillance Study: UK national audit of management and outcomes of angiosarcoma of the breast and chest wall. Br J Surg 2021; 108:388-394. [PMID: 33749771 DOI: 10.1093/bjs/znaa128] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2020] [Accepted: 11/15/2020] [Indexed: 01/08/2023]
Abstract
BACKGROUND Breast angiosarcomas are rare tumours of vascular origin. Secondary angiosarcoma occurs following radiotherapy for breast cancer. Angiosarcomas have high recurrence and poor survival rates. This is concerning owing to the increasing use of adjuvant radiotherapy for the treatment of invasive breast cancer and ductal cancer in situ (DCIS), which could explain the rising incidence of angiosarcoma. Outcome data are limited and provide a poor evidence base for treatment. This paper presents a national, trainee-led, retrospective, multicentre study of a large angiosarcoma cohort. METHODS Data for patients with a diagnosis of breast/chest wall angiosarcoma between 2000 and 2015 were collected retrospectively from 15 centres. RESULTS The cohort included 183 patients with 34 primary and 149 secondary angiosarcomas. Median latency from breast cancer to secondary angiosarcoma was 6 years. Only 78.9 per cent of patients were discussed at a sarcoma multidisciplinary team meeting. Rates of recurrence were high with 14 of 28 (50 per cent ) recurrences in patients with primary and 80 of 124 (64.5 per cent ) in those with secondary angiosarcoma at 5 years. Many patients had multiple recurrences: total of 94 recurrences in 162 patients (58.0 per cent). Median survival was 5 (range 0-16) years for patients with primary and 5 (0-15) years for those with secondary angiosarcoma. Development of secondary angiosarcoma had a negative impact on predicted breast cancer survival, with a median 10-year PREDICT prognostic rate of 69.6 per cent, compared with 54.0 per cent in the observed cohort. CONCLUSION A detrimental impact of secondary angiosarcoma on breast cancer survival has been demonstrated. Although not statistically significant, almost all excess deaths were attributable to angiosarcoma. The increased use of adjuvant radiotherapy to treat low-risk breast cancer and DCIS is a cause for concern and warrants further study.
Collapse
Affiliation(s)
- J Banks
- Department of Breast Surgery, Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK
| | - J George
- Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, UK.,Department of General Surgery, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
| | - S Potter
- Southmead Hospital, North Bristol NHS Trust, Bristol, UK.,Bristol Centre for Surgical Research, Population Health Sciences, Bristol Medical School, Bristol, UK
| | - M D Gardiner
- Department of Plastic Surgery, Frimley Health Foundation NHS Trust, Frimley, UK.,Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK
| | - C Ives
- Department of Breast Surgery, Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK
| | - A M Shaaban
- Department of Cellular Pathology, Queen Elizabeth Hospital, Birmingham, UK.,Department of Cellular Pathology, University of Birmingham, Birmingham, UK
| | - J Singh
- Department of Breast Surgery, Surrey and Sussex Healthcare NHS Trust, Redhill, UK
| | - J Sherriff
- Department of Oncology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
| | - M T Hallissey
- Department of General Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
| | - K Horgan
- Department of General Surgery, Leeds Teaching Hospitals NHS Trust, Leeds, UK
| | - A Harnett
- Department of Oncology, Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, UK
| | - A Desai
- Department of General Surgery, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK
| | - D J Ferguson
- Department of Breast Surgery, Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK
| | - R Tillett
- Department of Plastic Surgery, Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK
| | - D Izadi
- Department of Plastic Surgery, Royal Devon and Exeter Hospital NHS Foundation Trust, Exeter, UK
| | - H Sadideen
- Department of Surgery and Cancer, Imperial College London, London, UK
| | - A Jain
- Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK.,Department of Plastic and Reconstructive surgery, Imperial College Healthcare NHS Trust, London, UK
| | - C Gerrand
- Royal National Orthopaedic Hospital NHS Trust, Stanmore, UK
| | - C Holcombe
- British Association of Plastic, Reconstructive and Aesthetic Surgeons, London, UK.,Linda McCartney Centre, Royal Liverpool and Broadgreen University Hospitals NHS Foundation Trust, Liverpool, UK
| | - A Hayes
- Sarcoma and Melanoma Unit, Department of Academic Surgery, Royal Marsden Hospital, London, UK
| | - V Teoh
- Sarcoma and Melanoma Unit, Department of Academic Surgery, Royal Marsden Hospital, London, UK
| | - L Wyld
- Department of Oncology and Metabolism, The Medical School, University of Sheffield, Sheffield, UK
| | | |
Collapse
|
2
|
Gilmour A, Cutress R, Gandhi A, Harcourt D, Little K, Mansell J, Murphy J, Pennery E, Tillett R, Vidya R, Martin L. Oncoplastic breast surgery: A guide to good practice. Eur J Surg Oncol 2021; 47:2272-2285. [PMID: 34001384 DOI: 10.1016/j.ejso.2021.05.006] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2021] [Revised: 04/18/2021] [Accepted: 05/05/2021] [Indexed: 02/08/2023] Open
Abstract
Oncoplastic Breast Surgery has become standard of care in the management of Breast Cancer patients. These guidelines written by an Expert Advisory Group; convened by the Association of Breast Surgery (ABS) and the British Association of Plastic, Reconstructive and Aesthetic Surgeons (BAPRAS), are designed to provide all members of the breast cancer multidisciplinary team (MDT) with guidance on the best breast surgical oncoplastic and reconstructive practice at each stage of a patient's journey, based on current evidence. It is hoped they will also be of benefit to the wide range of professionals and service commissioners who are involved in this area of clinical practice.
Collapse
Affiliation(s)
- A Gilmour
- Canniesburn Plastic Surgery Unit, Glasgow Royal Infirmary, United Kingdom
| | - R Cutress
- University of Southampton and University Hospital Southampton, United Kingdom
| | - A Gandhi
- Manchester Academic Health Sciences Centre & Manchester University Hospitals NHS Trust, Manchester, United Kingdom
| | - D Harcourt
- Centre for Appearance Research, University of the West of England, Bristol, United Kingdom
| | - K Little
- Liverpool Breast Unit, Liverpool University Foundation Trust, United Kingdom
| | - J Mansell
- Gartnavel General Hospital, Glasgow, United Kingdom
| | - J Murphy
- Manchester University Hospitals NHS Trust, United Kingdom
| | | | - R Tillett
- Royal Devon and Exeter NHS Trust, Exeter, United Kingdom
| | - R Vidya
- The Royal Wolverhampton NHS Trust, Wolverhampton, United Kingdom
| | - L Martin
- Liverpool Breast Unit, Liverpool University Foundation Trust, United Kingdom.
| |
Collapse
|
3
|
Wildgoose J, McCrindle D, Tillett R. The Exeter half-day release psychotherapy training scheme – a model for others? Psychiatr bull 2018. [DOI: 10.1192/pb.26.1.31] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Training in psychotherapy is a mandatory part of general professional training in psychiatry. The College produced guidelines in 1993 outlining the breadth and depth of training required (Royal College of Psychiatrists, 1993).
Collapse
|
4
|
Youssef MMG, Rees-Lee J, Burden M, Olsen S, Ferguson D, Tillett R. Re: Infection prevention in implant surgery - A review of the surgical evidence, guidelines and a checklist. Eur J Surg Oncol 2016; 42:1769-1770. [PMID: 27503442 DOI: 10.1016/j.ejso.2016.07.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2016] [Accepted: 07/08/2016] [Indexed: 11/18/2022] Open
Affiliation(s)
- M M G Youssef
- Department of Breast Surgery, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
| | - J Rees-Lee
- Department of Breast Surgery, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
| | - M Burden
- Infection Prevention & Control Department, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
| | - S Olsen
- Department of Breast Surgery, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
| | - D Ferguson
- Department of Breast Surgery, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
| | - R Tillett
- Department of Breast Surgery, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK
| |
Collapse
|
5
|
Potter S, Ward J, Cawthorn S, Holcombe C, Warr R, Wilson S, Tillett R, Weiler-Mithoff E, Winters Z, Barker J, Oates C, Harcourt D, Brookes S, Blazeby J. Abstract P4-17-03: Towards the standardisation of outcome reporting in reconstructive breast surgery: Initial results of the BRAVO (Breast Reconstruction and Valid Outcome) Study–A multicentre consensus process to develop a core outcome set for reconstructive breast surgery. Cancer Res 2012. [DOI: 10.1158/0008-5472.sabcs12-p4-17-03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: Appropriate outcome selection is essential if research is to guide decision-making for patients, professionals and policy makers. Systematic reviews evaluating the clinical, cosmetic and patient-reported outcomes of breast reconstruction, however, have demonstrated marked heterogeneity of outcome reporting such that results from individual studies cannot be compared or combined. Standardising end-points by developing and using core outcome sets - an agreed minimum set of outcomes that should be measured and reported in all research and audit studies – is one way by which outcome reporting may be improved. We therefore report the initial results of the BRAVO (Breast Reconstruction and Valid Outcomes) Study which aims to use a scientifically rigorous Delphi consensus process to develop a core outcome set for reconstructive breast surgery.
Methods: The Delphi process involves the sequential completion of questionnaires to allow stakeholder opinions to be synthesised using item responses to prioritise outcome domains.
The questionnaire was developed from a long list of 148 outcomes generated from literature reviews and qualitative work with stakeholders. The outcomes were categorised into 34 domains in six categories (short-term complications; late complications; symptoms; psychosocial issues; practical issues and cosmesis) and each domain operationalised.
Key stakeholders were identified as patients, surgeons, specialist nurses and psychologists and participants were sampled purposively to ensure a breadth of perspectives. Each participant was sent a questionnaire and asked to prioritise the outcomes on a nine-point likert scale from 1(not important) to 9(extremely important).
The number of respondents in each group rating each outcome as not important(scores 1–3); equivocal(scores 4–6) or very important(score 7–9) were calculated for each item and compared between groups. The proportions of respondents rating each item as very important(score 7–9) was used to rank the items.
Results: 213 of the 430 questionnaires were returned(126/274 patients and 87/156 professionals) giving a response rate of 49.5%.
Patient participants had a median age of 53.4 years(range 34–76) and had undergone a full range of reconstructive procedures. The professional group included 39 breast surgeons, 20 plastic surgeons and 18 clinical nurse specialists.
There was agreement between 7 of the 10 outcomes that each group rated most highly. Items with consensus included patient-reported cosmesis, cosmetic satisfaction and early complications. Patients, but not professionals, considered generic complications such as bleeding to be important while professionals valued psychosocial issues such as self-esteem more highly than patients.
Conclusions: Patients and professionals prioritise similar outcomes, but areas of discrepancy with regard to complications and psychosocial outcomes remain. A further Delphi round asking participants to re-prioritise outcomes and a consensus meeting to ratify the final decisions will be necessary to determine a final core outcome set for reconstructive breast surgery.
Citation Information: Cancer Res 2012;72(24 Suppl):Abstract nr P4-17-03.
Collapse
Affiliation(s)
- S Potter
- University of Bristol, United Kingdom; North Bristol NHS Trust, Bristol, United Kingdom; Linda McCartney Breast Centre, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom; University of the West of England, Bristol, United Kingdom
| | - J Ward
- University of Bristol, United Kingdom; North Bristol NHS Trust, Bristol, United Kingdom; Linda McCartney Breast Centre, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom; University of the West of England, Bristol, United Kingdom
| | - S Cawthorn
- University of Bristol, United Kingdom; North Bristol NHS Trust, Bristol, United Kingdom; Linda McCartney Breast Centre, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom; University of the West of England, Bristol, United Kingdom
| | - C Holcombe
- University of Bristol, United Kingdom; North Bristol NHS Trust, Bristol, United Kingdom; Linda McCartney Breast Centre, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom; University of the West of England, Bristol, United Kingdom
| | - R Warr
- University of Bristol, United Kingdom; North Bristol NHS Trust, Bristol, United Kingdom; Linda McCartney Breast Centre, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom; University of the West of England, Bristol, United Kingdom
| | - S Wilson
- University of Bristol, United Kingdom; North Bristol NHS Trust, Bristol, United Kingdom; Linda McCartney Breast Centre, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom; University of the West of England, Bristol, United Kingdom
| | - R Tillett
- University of Bristol, United Kingdom; North Bristol NHS Trust, Bristol, United Kingdom; Linda McCartney Breast Centre, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom; University of the West of England, Bristol, United Kingdom
| | - E Weiler-Mithoff
- University of Bristol, United Kingdom; North Bristol NHS Trust, Bristol, United Kingdom; Linda McCartney Breast Centre, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom; University of the West of England, Bristol, United Kingdom
| | - Z Winters
- University of Bristol, United Kingdom; North Bristol NHS Trust, Bristol, United Kingdom; Linda McCartney Breast Centre, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom; University of the West of England, Bristol, United Kingdom
| | - J Barker
- University of Bristol, United Kingdom; North Bristol NHS Trust, Bristol, United Kingdom; Linda McCartney Breast Centre, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom; University of the West of England, Bristol, United Kingdom
| | - C Oates
- University of Bristol, United Kingdom; North Bristol NHS Trust, Bristol, United Kingdom; Linda McCartney Breast Centre, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom; University of the West of England, Bristol, United Kingdom
| | - D Harcourt
- University of Bristol, United Kingdom; North Bristol NHS Trust, Bristol, United Kingdom; Linda McCartney Breast Centre, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom; University of the West of England, Bristol, United Kingdom
| | - S Brookes
- University of Bristol, United Kingdom; North Bristol NHS Trust, Bristol, United Kingdom; Linda McCartney Breast Centre, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom; University of the West of England, Bristol, United Kingdom
| | - J Blazeby
- University of Bristol, United Kingdom; North Bristol NHS Trust, Bristol, United Kingdom; Linda McCartney Breast Centre, Royal Liverpool and Broadgreen University Hospitals NHS Trust, Liverpool, United Kingdom; NHS Greater Glasgow and Clyde, Glasgow, United Kingdom; University of the West of England, Bristol, United Kingdom
| |
Collapse
|
6
|
Georgeu GA, Walbeehm ET, Tillett R, Afoke A, Brown RA, Phillips JB. Investigating the mechanical shear-plane between core and sheath elements of peripheral nerves. Cell Tissue Res 2005; 320:229-34. [PMID: 15761768 DOI: 10.1007/s00441-004-1031-2] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2004] [Accepted: 10/25/2004] [Indexed: 10/25/2022]
Abstract
The mechanical architecture of rat sciatic nerve has been described as a central core surrounded by a sheath, although the way in which these structures contribute to the overall mechanical properties of the nerve is unknown. We have studied the retraction responses of the core and sheath following transection, together with their tensile properties and the interface between them. Nerves were harvested and maintained at their in situ tension and then either transected entirely, through the sheath only, or through an exposed section of the core. The retraction of each component was measured within 5 min and again after 45 min. Post mortem loss of retraction was tested 0 min or 60 min after excision. For fresh nerves, immediate retraction was 12.68% (whole nerve), 5.35% (sheath) and 4% (core), with a total retraction of 15%, 7.21% and 5.26% respectively. For stored nerves, immediate retraction was 5.33% (whole nerve) and 5.87% (sheath), with an extension of 0.78% for core, and a total retraction of 6.71% and 7.87% and an extension of 1.74%, respectively. Tensile extension and pullout force profiles were obtained for the sheath, the core and the interface between them. These showed a consistent hierarchy of break strengths that would, under increasing load, result in failure of the interface, then the core and finally the sheath. These data reflect the contributions of material tension and fluid swelling pressure to total retraction, and the involvement of an energy-dependent process that runs down rapidly post mortem. This study increases our understanding of the composite nature of peripheral nerve tissue architecture and quantifies the material properties of the distinct elements that contribute to overall mechanical function.
Collapse
Affiliation(s)
- G A Georgeu
- Tissue Repair and Engineering Centre, Institute of Orthopaedics and Musculoskeletal Science, University College London, UK
| | | | | | | | | | | |
Collapse
|
7
|
Abstract
BACKGROUND Current acceptance of the need for a wide range of treatments and growing pressure for cost-effectiveness suggest the need for a more discriminating approach to assessment of psychotherapy. METHOD Medline and manual literature searches, and personal experience of over 1000 assessments in a district psychotherapy service. RESULTS There is substantial evidence for the general efficacy of psychotherapy; differential benefits are beginning to be identified. Short-term treatments are appropriate in a wide variety of situations and can be surprisingly effective. Chronic/complex psychopathology is likely to need longer term therapy. CONCLUSIONS Effective use of scarce psychotherapy resources requires knowledge of the research evidence of treatment effectiveness, careful assessment of the patient and a logical and collaborative approach to treatment planning.
Collapse
|
8
|
Tillett R. Accreditation of psychotherapists: what and how? Br J Hosp Med (Lond) 1994; 52:481. [PMID: 7874365] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/27/2023]
|
9
|
|
10
|
|
11
|
Abstract
Gestalt therapy was developed by Frederick (Fritz) Perls, (1893–1970), a German psychoanalyst originally trained in the Freudian tradition; he left Germany in the 1930's for South Africa and emigrated to the United States in the immediate post-war years. Despite the publication of his book “Gestalt Therapy—Excitement and Growth in the Human Personality” (Perls, Hefferline and Goodman, 1950) his work remained relatively little known until Gestalt Therapy was taken up enthusiastically by the growth movement in the early 1960's. Although it is widely regarded as an established therapy in the United States, Gestalt remains relatively little known in the United Kingdom and there are probably few psychiatrists who are familiar with its theory and techniques. This paper is intended to present an introduction to Gestalt Therapy together with some idea of its application in clinical psychiatric practice.
Collapse
|